NCT05521074View on ClinicalTrials.gov

Transcranial Direct Current Stimulation Potentiation of Fear Extinction in OCD

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Obsessive-Compulsive Disorder
Interventions
DEVICE

Active tDCS

The investigators will use commercially available tDCS equipment (Neuroelectrics©, Barcelona, Spain). The cathode will be placed over the pre-SMA using the 10-20 EEG system and the anode will be on the right deltoid.

DEVICE

Sham tDCS

The investigators will use commercially available tDCS equipment (Neuroelectrics©, Barcelona, Spain). The cathode will be placed over the pre-SMA using the 10-20 EEG system and the anode will be on the right deltoid. tDCS will not be active in this condition.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

collaborator

Foundation for OCD Research

UNKNOWN